Description

Health Canada carried out this safety review when it became aware that the FDA was investigating the risk of angle-closure glaucoma linked to antidepressant use. Angle-closure glaucoma is a serious eye disorder where eye fluid drainage is blocked, leading to a sudden increase in the pressure in the eye and causing pain and blurred vision. If not treated immediately, angle-closure glaucoma can lead to permanent vision loss.

Resources

Name	Format	Description	Link
Summary Safety Review - Antidepressants - Assessing the Potential Risk of Serious Eye Disorder (Angle-Closure Glaucoma)	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/safety-reviews/summary-safety-review-hormone-replacement-therapy-estrogenic-progestogenic-agents-selective-estrogen-receptor-modulators-serms-assessing-potential.html
Summary Safety Review - Antidepressants - Assessing the Potential Risk of Serious Eye Disorder (Angle-Closure Glaucoma)	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medeffet-canada/examens-innocuite/resume-examen-innocuite-traitement-hormonal-substitutif-strogenes-progestatifs-modulateurs-selectifs-recepteurs.html

Tags

Topics

Categories